5Stahl SM. Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects. J Clin Psychiatry, 1998,59 Suppl 18:23-29.
6Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry, 1991,48:851-855.
7The World Health Organization. The world health report 2004 : annex table 3 burden of disease in DALYs by cause, sex and mortality stratum in WHO regions, estimate for 2002, Geneva : World Health Organization, 2005. 127-131.
8Nierenberg AA, Wright EC. Evolution of remission as the new standard in the treatment of depression. J Clin Psychiatry, 1999, 60Suppl 22:7-11.
9Kelsey JE. Achieving remission in major depressive disorder: the first step to long-term recovery. J Am Osteopath Assoc, 2004, 104(3 Suppl 3) :S6-10.
10Montgomery SA, Mahe V, Haudiquet V, et al. Effectiveness of venlafaxine, extended release formulation, in the short-term and long-term treatment of generalized anxiety disorder: results of a survival analysis. J Clin Psychopharmacol, 2002, 22:561-567.
